Wearable technology to observe Covid-19 trends
The Nanowear Wearable Covid-19 Observational and Analysis Trend
This study is testing a special vest that collects health data from hospitalized Covid-19 patients to help us understand the disease better.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Nanowear Inc. Industry-sponsored |
| Locations | 2 sites (Hackensack, New Jersey and 1 other locations) |
| Trial ID | NCT04717024 on ClinicalTrials.gov |
What this trial studies
The NanoCOAT study is an observational study that aims to collect and analyze physiological and biometric data from hospitalized patients diagnosed with Covid-19. It will enroll between 10 to 100 subjects across multiple sites to assess trends related to the disease. Participants will wear a vest designed to monitor their health metrics during their hospital stay. This study does not involve any interventions but focuses on gathering valuable data to understand Covid-19 better.
Who should consider this trial
Good fit: Ideal candidates are hospitalized adults over 18 years old with a primary diagnosis of Covid-19.
Not a fit: Patients who are pregnant, intubated, or have an implantable cardiac device will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into the physiological effects of Covid-19, potentially improving patient monitoring and treatment strategies.
How similar studies have performed: While observational studies on Covid-19 have been conducted, the specific use of wearable technology for this purpose is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Subject has provided informed consent * Male or female over the age of 18 years * The patient is currently hospitalized with a primary diagnosis of Covid-19 Exclusion Criteria: * Subject is unwilling or unable to wear the vest during hospitalization. * Subjects who are pregnant. * Subject is intubated or admitted to ICU * Subject has an implantable cardiac device (i.e pacemaker or internal cardioverter defibrillator)
Where this trial is running
Hackensack, New Jersey and 1 other locations
- Hackensack University Medical Center — Hackensack, New Jersey, United States (Not_yet_recruiting)
- Maimonides Medical Center — Brooklyn, New York, United States (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.